Knee height and arm span
A reflection of early life environment and risk of dementia
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objectives: To determine if anthropometric measures, as markers of early life environment, are associated with risk of dementia, Alzheimer disease (AD), and vascular dementia (VaD).
Methods: A total of 2,798 subjects were followed as part of the Cardiovascular Health Cognition Study for an average of 5.4 years; 480 developed dementia. Knee height was measured 3 years prior to and arm span 4 years after the study’s baseline. Cox proportional hazard models were used to examine their association with subsequent risk of dementia, AD, and VaD.
Results: Among women, greater knee height and arm span were associated with lower risks of dementia (knee height: HR per 1-inch increase 0.84; 95% CI 0.74–0.96; arm span: HR per 1-inch increase 0.93; 95% CI 0.88–0.98) and AD (knee height: HR per 1-inch increase 0.78; 95% CI 0.65–0.93; arm span: HR per 1-inch increase 0.90; 95% CI 0.85–0.96). Women in the lowest quartile of arm span had ∼1.5 times greater risk of dementia (HR 1.45; 95% CI 1.03–2.05) and AD (HR 1.70; 95% CI 1.10–2.62) than other women. Among men, only arm span was associated with lower risks of dementia (HR per 1-inch increase 0.94; 95% CI 0.89–1.00) and AD (HR per 1-inch increase 0.92; 95% CI 0.84–1.00). For each gender, knee height was not associated with VaD, while arm span was associated with a nonsignificant lower risk of VaD.
Conclusions: Our findings with knee height and arm span are consistent with previous reports and suggest early life environment may play an important role in the determination of future dementia risk.
Glossary
- 3MSE=
- Modified Mini-Mental State Examination;
- AD=
- Alzheimer disease;
- ADDTC=
- Alzheimer’s Disease Diagnostic and Treatment Centers;
- CHS=
- Cardiovascular Health Study;
- DSM-IV=
- Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition;
- MMSE=
- Mini-Mental State Examination;
- NINCDS-ADRDA=
- National Institute of Neurological and Communicative Diseases and Stroke–Alzheimer’s Disease and Related Disorders Association;
- NINDS-AIREN=
- National Institute of Neurological Diseases and Stroke–Association Internationale pour la Recherche et l’Enseignement en Neurosciences;
- VaD=
- vascular dementia.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Mark Burish and Dr. Emmanuelle Schindler
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Benefits of fatty fish on dementia risk are stronger for those without APOE ε4T. L. Huang, P. P. Zandi, K. L. Tucker et al.Neurology, November 07, 2005 -
Articles
NSAID use and dementia risk in the Cardiovascular Health Study*Role of APOE and NSAID typeC. A. Szekely, J.C.S. Breitner, A. L. Fitzpatrick et al.Neurology, November 14, 2007 -
Articles
Relation between smoking and risk of dementia and Alzheimer diseaseThe Rotterdam StudyC. Reitz, T. den Heijer, C. van Duijn et al.Neurology, September 04, 2007 -
Articles
Determinants of vascular dementia in the Cardiovascular Health Cognition StudyL. H. Kuller, O. L. Lopez, W. J. Jagust et al.Neurology, May 09, 2005